Systemic absorption of the sunscreens benzophenone-3, octyl- methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans

Journal of Investigative Dermatology

Volumn 123, Issue 1, 2004, Pages 57-61

  Janjua, Nadeem Rezaq ^a   Mogensen, Brian ^a   Andersson, Anna Maria ^b   Petersen, Jørgen Holm ^b   Henriksen, Mette ^a   Skakkebæk, Niels E ^b   Wulf, Hans Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Excretion; Human; Reproductive hormones; Sunscreens; Systemic absorption; Topical application

Indexed keywords

BENZOPHENONE DERIVATIVE; BENZYLIDENE DERIVATIVE; CAMPHOR DERIVATIVE; ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; SUNSCREEN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG EXPOSURE; DRUG PENETRATION; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SKIN ABSORPTION; SKIN PENETRATION; TESTOSTERONE BLOOD LEVEL;

EID: 3042691083     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22725.x     Document Type: Article

References (15)

1. Bech-Thomsen N, Wulf HC: Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed 9:242-244, 1992-1993
2. Castelo-Branco C, Martinez de Osaba MJ, Vanrezc JA, Fortuny A, Gonzalez-Merlo J: Effects of oophorectomy and hormonereplacement therapy on pituitary-gonadal function. Maturitas 17:101-111, 1993
3. Cusack B, Evestal R: Pharmacology. In: Beers MH, Berkow R (eds). The Merck Manual of Geriatrics, 3rd edn. Merck & Company, Inc., 2000; p 54-74
4. Deutsches Institut für Normung: Experimentelle dermatologische Bewertung des Erythemschutzes von externen sonnenshutzmitteln fûr die menschliche Haut 67501: 1-7, DIN 1985
5. Gagliardi I, Amato A, Basili A, Cavazutti G, Tonelli D: Determination of sun-screen agents in cosmetic products by reversed-phase high-performance liquid chromatography. J Chromatogr 408:409-415, 1987
6. Gupta VK, Zatz JL, Rerek M: Percutaneous absorption of sunscreens through micro-Yucatan pig skin in vitro. Pharm Res 16:1602-1607, 1999
7. Gustavson Gonzalez H, Farbrot A, Iarko O: Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol 27:691-694, 2002
8. Hagedorn-Leweke U, Lippold BC: Absorption of suncreens and other compounds through human skin in vivo: Derivation of a method to predict maximum fluxes. Pharm Res 12:1354-1360, 1995
9. Hayden CG, Roberts MS, Benson HA: Systemic absorption of sunscreen after topical application. Lancet 350:863-864, 1997
10. Lind T, Cameron EC, Hunter WN, et al: A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol 86 (Suppl. 3):1-29, 1979
11. Lowe NJ: Photoprotection. In: Hawk JLM (ed). Photodermatology. London: Chapman & Hall, 1998; p 213-221
12. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W: In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 109:239-244, 2001
13. Stender IM, Lock-Andersen J, Wulf HC: Sun-protection behaviour and self-assessed burning tendency among sunbathers. Photodermatol Photoimmunol Photomed 12:162-165, 1996a
14. Stender IM, Lock-Andersen J, Wulf HC: Sun exposure and sunscreen use among sunbathers in Denmark. Acta Derm Venereol 76:31-33, 1996b
15. Wulf HC, Stender IM, Lock-Andersen J: Sunscreens used at the beach do not protect against erythema: A new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 13:129-132, 1997